GlassScriptPhysician profile
Vivian Hutton
NPI 1477548626
$1,990.11
in general payments reported to CMS, 2019-2025
22 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $95.16 · 2022: $617 · 2023: $591 · 2024: $369 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,278.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $293.30 | 2022-2024 | Eliquis, Camzyos |
| Cvrx, INC. | $287.37 | 2022-2025 | Barostim Neo System |
| Pfizer INC. | $253.08 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $214.64 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $175.11 | 2022-2025 | |
| Scpharmaceuticals INC. | $89.32 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $86.03 | 2022-2024 | Verquvo |
| Abiomed | $83.04 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.30 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $77.24 | 2022-2025 | Farxiga, Andexxa |
| Philips North America LLC | $57.54 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Medtronic, INC. | $55.77 | 2021-2024 | Linq II |
| Abbott Laboratories | $43.30 | 2022 | |
| Stryker Corporation | $26.71 | 2025 | Flowtriever |
| Amgen INC. | $26.30 | 2023-2025 | Repatha, Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.22 | 2025 | General - Therapies |
| Inari Medical, INC. | $24.80 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Solventum Corporation | $21.88 | 2025 | Prevena, V.A.C.Ulta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.63 | 2022 | |
| Novo Nordisk INC | $18.88 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $18.15 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Hutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.